Please login to the form below

Not currently logged in
Email:
Password:

Activartis

This page shows the latest Activartis news and features for those working in and with pharma, biotech and healthcare.

FDA grants orphan status to Activartis’ brain cancer immunotherapy

FDA grants orphan status to Activartis’ brain cancer immunotherapy

Activartis' AV0113 is part of this growing trend, and the drug has shown promise in early-stage trials. ... time. According to Activartis, preliminary results revealed a “very promising trend” towards overall survival benefit in patients taking AV0113

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
...
How to keep your weight under control during lockdown
...
Brands stepping up to show solidarity during COVID-19
The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....

Infographics